Differential Modulation of Biological Properties In Vitro by a Range of cRGDY Peptides on Clinically Translated Dual-Modality Silica Nanoparticles

Miriam Benezra

Memorial Sloan-Kettering Cancer Center, New York, NY

Dr. Benezra completed her Ph.D. and Pharmacy degree at the Hebrew University, Israel. Her postdoctoral training she did at the Mount Sinai School of Medicine in, New York (NY). Now, she is working at Memorial Sloan Kettering Cancer Center in NY in the Department of Radiology in the area of developing nanoparticles for diagnostic and therapeutic purposes for medicine. During her career Dr. Benezra published over 30 articles in peer-reviewed journals. She is a permanent reviewer in several cell biology, cancer journals. Additionally, she has been serving as an editorial board member of repute Journals in nanotechnology and nano-medicine.

Abstract

Introduction: Ultra-small Dual Modality nanoparticles, termed Cornell dots (i.e., C’ dots) may provide a disease-directed platform for delivery of small cancer molecules for theranostic purposes. For clinical advancement of... [ view full abstract ]

Authors

  1. Miriam Benezra (Memorial Sloan-Kettering Cancer Center, New York, NY)
  2. Pauliah Mohan (Memorial Sloan-Kettering Cancer Center, New York, NY)
  3. Ulrich Weisner (Cornell University, Ithaca, NY)
  4. Michelle Bradbury (Memorial Sloan-Kettering Cancer Center, New York, NY)

Topic Areas

Nanomedecine for cancer diagnosis & therapy , Nano-Imaging for diagnosis, therapy and delivery

Session

OS2-103 » Nanomedecine for cancer diagnosis & therapy (16:00 - Thursday, 29th September, Tower 24 - Room 103)

Presentation Files

The presenter has not uploaded any presentation files.